Delivery Order SPE2DR25D2103-SPE2DR26F91UT
- Not listed
- The Defense Logistics Agency awarded a $1,999.74 delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin in 3 mL quantities. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 19, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,252.93 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin in 3mL vials, with an ultimate completion date of September 11, 2025. This non-set-aside, competitively awarded contract reflects firm fixed pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,403.24 for Lantus SoloStar 100 Unit/mL 3mL insulin on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities, with a ceiling value of $1,967.64 and an ultimate completion date of December 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award...
- The Defense Logistics Agency awarded a $9,503.98 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar insulin (100 units/mL in 3mL formulation) on October 27, 2025, with completion targeted for October 28, 2025. This is a firm fixed-price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $1,151.89 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML insulin in 3ML quantities. This competitively awarded, firm fixed-price contract with an ultimate completion date of December 16, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed and delivered from AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,382.57 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. This competitive award, executed on May 27, 2025, with an ultimate completion date of May 28, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This order represents a child...
- The Defense Logistics Agency awarded a $1,980.00 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin on October 20, 2025, with completion scheduled for October 21, 2025. This non-competitive, firm fixed-price delivery order represents a pharmaceutical procurement fulfilled by AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The award is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,073.75 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin products. The award was made on December 10, 2025, with an ultimate completion date of December 11, 2025, and represents a firm fixed price, non-set-aside delivery order. Performance will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,237.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL pen format, with completion scheduled for November 10, 2025. This is a non-set-aside competitive award issued to the Conshohocken, Pennsylvania-based pharmaceutical distributor, which serves as a critical vendor for federal medical procurement. The delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D2103Indefinite Delivery Contract
- SPE2DR25D2103-SPE2DR26F91UTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,980.00 to AmerisourceBergen Drug Corp for Lantus SoloStar insulin (100 units/mL, 3mL formulation) on December 18, 2025, with completion scheduled for December 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and veteran healthcare supply needs through the DLA Medical Supply Chain. The company's prime IDC enables the delivery of a comprehensive range of pharmaceutical products and medical supplies—including specialty medications, vaccines, and branded drugs—to support military healthcare programs globally. This particular delivery order for insulin aligns with AmerisourceBergen's extensive portfolio of diabetes and specialty medication deliveries to federal health systems, demonstrating the vendor's continued role in supplying essential pharmaceutical commodities to the Defense Health Agency and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 12/17/25 |